[go: up one dir, main page]

JPS63500243A - 慢性閉塞性肺疾患の治療方法および組成物 - Google Patents

慢性閉塞性肺疾患の治療方法および組成物

Info

Publication number
JPS63500243A
JPS63500243A JP61504010A JP50401086A JPS63500243A JP S63500243 A JPS63500243 A JP S63500243A JP 61504010 A JP61504010 A JP 61504010A JP 50401086 A JP50401086 A JP 50401086A JP S63500243 A JPS63500243 A JP S63500243A
Authority
JP
Japan
Prior art keywords
calcium channel
perapamil
administered
gallopamil
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61504010A
Other languages
English (en)
Japanese (ja)
Inventor
アーメド，タヒル
サックナー，マーヴィン
Original Assignee
キ−・ファ−マシュ−ティカルス・インコ−ポレ−テッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キ−・ファ−マシュ−ティカルス・インコ−ポレ−テッド filed Critical キ−・ファ−マシュ−ティカルス・インコ−ポレ−テッド
Publication of JPS63500243A publication Critical patent/JPS63500243A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP61504010A 1985-07-02 1986-07-01 慢性閉塞性肺疾患の治療方法および組成物 Pending JPS63500243A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75111485A 1985-07-02 1985-07-02
US751114 1985-07-02

Publications (1)

Publication Number Publication Date
JPS63500243A true JPS63500243A (ja) 1988-01-28

Family

ID=25020531

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61504010A Pending JPS63500243A (ja) 1985-07-02 1986-07-01 慢性閉塞性肺疾患の治療方法および組成物

Country Status (8)

Country Link
EP (1) EP0231266A1 (fi)
JP (1) JPS63500243A (fi)
KR (1) KR890004691B1 (fi)
AU (1) AU601695B2 (fi)
DK (1) DK103087D0 (fi)
FI (1) FI870731L (fi)
MY (1) MY100519A (fi)
WO (1) WO1987000047A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430128A1 (de) * 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
CA2687013C (en) 2009-12-03 2018-09-04 Kenneth W. Adams Method and composition for treatment and prevention of broad spectrum virus ailments
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440881A1 (de) * 1984-11-06 1986-05-15 Schering AG, Berlin und Bergkamen, 1000 Berlin Pharmazeutische zusammensetzung, ihre herstellung und verwendung

Also Published As

Publication number Publication date
FI870731A7 (fi) 1987-02-20
DK103087A (da) 1987-02-27
MY100519A (en) 1990-10-30
KR870700349A (ko) 1987-12-28
AU601695B2 (en) 1990-09-20
EP0231266A1 (en) 1987-08-12
KR890004691B1 (ko) 1989-11-25
FI870731A0 (fi) 1987-02-20
FI870731L (fi) 1987-02-20
DK103087D0 (da) 1987-02-27
WO1987000047A1 (en) 1987-01-15
AU6141486A (en) 1987-01-30

Similar Documents

Publication Publication Date Title
CA2359813C (en) Nicotine mucosal spray
Sutton et al. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy.
AU775588B2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
US5656255A (en) Composition to help stop smoking
EP1446119B1 (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
CA2507159A1 (en) Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
SI9200403B (en) New combination of a bronchodilator and a steroidal antiinflammatory drug for treatment of respiratory disorders as well as its use and preparation thereof
JPH08505157A (ja) 局所麻酔薬の投与による気管支ぜん息の処置のための方法
CA2277365A1 (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
EP1718336A2 (en) Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
EP0218679B1 (en) Aerosol compositions for nasal delivery of vitamin b 12
US4606920A (en) Pharmaceutical composition suitable for treatment of inflammatory changes of the bronchial mucosa
JPS63500243A (ja) 慢性閉塞性肺疾患の治療方法および組成物
KR20050085104A (ko) 로플루미래스트와 포르모테롤을 포함하는 신규한상승작용성 조합물
Hockley et al. A comparison of three high doses of ipratropium bromide in chronic asthma
JPH01228912A (ja) エアロゾル形態のペンタミジンを用いるニユーモシスチス・カリニ肺炎の予防方法
CA2506956C (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
KR880003973A (ko) 약리적 활성 화합물 및 용도
Barach Repeated bronchial relaxation in the treatment of intractable asthma
Shah et al. Breathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalation
US4010269A (en) Antiviral quinazoline compositions and methods of use
Robuschi et al. Prevention of fog-induced bronchospasm by high doses of ipratropium bromide in asthmatics
JPS63500307A (ja) 気管支痙攣性気道疾患を治療するための方法および組成物
JPWO2017177966A5 (fi)
Schwarz Intranasal Corticotrophin in Hay Fever